Dengler, J., Schönland, S., Hundemer, M., Kristen, A., Dengler, T., Zeier, M., . . . Goldschmidt, H. (2004). High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: A single centre prospective phase II study. British journal of haematology, 127(5), . https://doi.org/10.1111/j.1365-2141.2004.05232.x
Chicago-Zitierstil (17. Ausg.)Dengler, Jolanta, Stefan Schönland, Michael Hundemer, Arnt Kristen, Thomas Dengler, Martin Zeier, Reinhold P. Linke, Anthony Dick Ho, und Hartmut Goldschmidt. "High-dose Melphalan with Autologous Stem Cell Transplantation After VAD Induction Chemotherapy for Treatment of Amyloid Light Chain Amyloidosis: A Single Centre Prospective Phase II Study." British Journal of Haematology 127, no. 5 (2004). https://doi.org/10.1111/j.1365-2141.2004.05232.x.
MLA-Zitierstil (9. Ausg.)Dengler, Jolanta, et al. "High-dose Melphalan with Autologous Stem Cell Transplantation After VAD Induction Chemotherapy for Treatment of Amyloid Light Chain Amyloidosis: A Single Centre Prospective Phase II Study." British Journal of Haematology, vol. 127, no. 5, 2004, https://doi.org/10.1111/j.1365-2141.2004.05232.x.